Results 311 to 320 of about 2,501,512 (375)

Evaluation of skin cancer prevention properties of probiotics. [PDF]

Genes Nutr
Torabi S, Nahidi Y, Ghasemi SZ, Reihani A, Samadi A, Ramezanghorbani N, Nazari E, Davoudi S.   +7 more
europepmc   +1 more source

Introducing an oncoplastic approach for centrally located breast cancer patients. [PDF]

World J Surg Oncol
Karoobi M, Yazd SMM, Aminolroaya F, Mahram H, Saghafinia S, Pompei S, Nafissi N, Khalili P.   +7 more
europepmc   +1 more source

Subacute cutaneous lupus erythematosus triggered by sintilimab: a case report. [PDF]

Front Immunol
Zhang C, Zhang X, Liang J, Liu Y, Chen J, Wang Q, Li C.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cutaneous Administration of Nitroglycerin: A Review

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1983
Chronic administration of nitroglycerin may have important therapeutic effects in patients with angina, acute myocardial infarction, congestive heart failure and peripheral vascular disease. Because of unpredictable oral absorption and short duration of action, topical preparations provide an alternative mode of administration.
Jay N. Cohn, Maria-Teresa Olivari
openaire   +4 more sources

CUTANEOUS ADMINISTRATION OF COD LIVER OIL

Archives of Pediatrics & Adolescent Medicine, 1926
The value of cod liver oil in preventing and in curing rickets has been heralded with extreme enthusiasm during the past few years, and recent literature has been filled with reports of investigations concerning its action, and concerning its apparently close relationship to the action of ultraviolet irradiation.
J. Garland
openaire   +3 more sources

Cutaneous Lesion Induced by a Subcutaneous Administration of Bortezomib [PDF]

Clinical Lymphoma Myeloma and Leukemia, 2012
Introduction A 78-year-old man presented to our hospital with an indurated, painful lesion on the abdominal wall at the site of a recent subcutaneous (SC) bortezomib injection. The patient was diagnosed with multiple myeloma (MM) in 2007 after a bone marrow biopsy was done as part of anemia workup.
Richard Ferrara, Karam M. Obeid, Mamta Sharma   +2 more
openaire   +2 more sources

Central administration of perfluorooctanoic acid inhibits cutaneous inflammation [PDF]

Inflammation Research, 2005
To elucidate the site of action of perfluorooctanoic acid (PFOA) in the carrageenan model of peripheral inflammation.Male Sprague-Dawley rats.We first compared the anti-edema effects of systemic PFOA (50-150 mg/kg) with prototypical nonsteroidal (acetylsalicylic acid, ASA, 50-200 mg/kg) and steroidal (dexamethasone, 0.5-5.0 mg/kg) drugs after the ...
S. Nagalingam, N. Dadia, C. Kriedt, Bradley K. Taylor, Mostafa Z. Badr   +4 more
openaire   +2 more sources

Cutaneous toxicity following the administration of dactinomycin

Medical and Pediatric Oncology, 1997
Dactinomycin (AMD) is an effective drug in the management of several malignant disorders and has been used for almost 40 years. Skin and subcutaneous toxicities following extravasation are well known and can be harmful. Similarly radiation-recall is a well established phenomenon following the administration of AMD.
John P. Arlette, Max J. Coppes, Keith Jorgenson   +2 more
openaire   +2 more sources